Tag: Cancer: Misc.
Most U.S. Adults Misunderstand Impact of Alcohol on Cancer Risk
Past-month alcohol consumption and believing cancer is not preventable linked to belief that alcohol has no impact on cancer risk
Prevalence of Key Cancer Susceptibility Genes Higher Than Expected
Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population
Statins Not Tied to Cognitive Decline in Patients Receiving Doxorubicin
No worsening seen in cognitive function over 24 months among patients with lymphoma or breast cancer receiving doxorubicin
FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma
Triplet combination treatment shows 51 percent reduction in the risk for death and tripled median progression-free survival versus a daratumumab-based triplet
Macrovascular Infiltration May Predict Cancer Mortality
Spikes in circulating tumor cell clusters identified immediately preceding death
Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma
Recurrence-free survival was numerically higher with adjuvant pembrolizumab, but difference was not significant
Abemaciclib + Endocrine Therapy Improves Survival in HR-Positive, HER2-Negative Early Breast Cancer
15.8 percent lower risk for death seen with abemaciclib-ET versus ET in intent-to-treat population
Sentinel Lymph Node Biopsy Noninferior to Lymphadenectomy in Cervical Cancer
Sentinel lymph node biopsy alone noninferior with respect to disease-free survival, linked to fewer complications
Loneliness, Social Isolation Tied to Higher Mortality in Patients With Cancer
Findings seen for both cancer-specific and all-cause mortality
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
Median duration of recurrence-free survival was 61.1 months with nivolumab and 24.2 months with ipilimumab
